v3.22.0.1
Statement of Consolidated Cash Flows - USD ($)
$ in Millions
12 Months Ended
Dec. 31, 2021
Dec. 31, 2020
Dec. 31, 2019
Operating Activities      
Net (loss) income $ (397) $ (109) $ 177
Adjustments to reconcile net (loss) income to cash (used for) provided from operations:      
Depreciation and amortization 253 251 252
Goodwill, Impairment Loss 65 0 0
Deferred income taxes (100) (16) (81)
Restructuring and other charges 624 188 87
Net periodic pension benefit cost 68 82 5
Stock-based compensation 22 23 40
Amortization of debt issuance costs 0 25 0
Other 21 (1) 10
Changes in assets and liabilities, excluding effects of acquisitions, divestitures, and foreign currency translation adjustments:      
(Increase) Decrease in receivables (381) (235) 2
(Increase) Decrease in inventories (596) 65 57
(Increase) Decrease in prepaid expenses and other current assets (1) (16) 10
Increase (Decrease) in accounts payable, trade 581 82 (100)
(Decrease) in accrued expenses (129) (217) (67)
Increase in taxes, including income taxes 21 99 41
Pension contributions (458) (271) (3)
(Increase) Decrease in noncurrent assets (8) 35 5
Increase in noncurrent liabilities 8 21 22
Cash (used for) provided from operations (407) 6 457
Financing Activities      
Net transfers from (to) former parent company 0 216 (296)
Separation payment to former parent company   (728) 0
Additions to debt (original maturities greater than three months) 319 2,400 0
Debt issuance costs (5) (57) 0
Payments on debt (original maturities greater than three months) 0 (1,100) 0
Other (18) 13 1
Cash provided from (used for) financing activities 135 744 (295)
Investing Activities      
Capital expenditures (184) (163) (201)
Proceeds from the sale of assets and businesses (1) (125) (31)
Payments for (Proceeds from) Other Investing Activities 4 0 0
Cash used for investing activities (181) (38) (170)
Effect of exchange rate changes on cash and cash equivalents and restricted cash 1 3 (1)
Net change in cash and cash equivalents and restricted cash (452) 715 (9)
Cash and cash equivalents and restricted cash at beginning of year 787 72 81
Cash and cash equivalents and restricted cash at end of year 335 787 72
Payments for Repurchase of Common Stock $ (161) $ 0 $ 0